Biosimilars in Ophthalmology

Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

On this page5 sections

Article Summary

Biosimilars in ophthalmology are copies of biologic drugs used to treat eye conditions, offering a potentially more affordable alternative to the original medications. These drugs, particularly anti-VEGF (vascular endothelial growth factor) agents, are crucial for managing retinal diseases like age-related macular degeneration (AMD) and diabetic macular edema. Biosimilars aim to provide the same therapeutic benefits as the reference biologics while reducing costs, which can improve patient access and...

Key Takeaways

  • This article explains What are Biosimilars? in simple medical language.
  • This article explains Biosimilars in Ophthalmology: in simple medical language.
  • This article explains Benefits of Biosimilars: in simple medical language.
  • This article explains Examples of Biosimilars in Ophthalmology: in simple medical language.
Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.
Biosimilars in ophthalmology are copies of biologic drugs used to treat eye conditions, offering a potentially more affordable alternative to the original medications. These drugs, particularly anti-VEGF (vascular endothelial growth factor) agents, are crucial for managing retinal diseases like age-related macular degeneration (AMD) and diabetic macular Biosimilars aim to provide the same benefits as the reference biologics while reducing costs, which can improve patient access and . 

What are Biosimilars?

  • Biosimilars are highly similar versions of biologic drugs that have already been approved. 
  • Unlike generic drugs, which are identical to the original medications, biosimilars are not exact copies due to the complexity of biologic molecules. 
  • They are developed to be highly similar in terms of structure, function, and efficacy to the reference biologic. 

Biosimilars in Ophthalmology:

  • Ophthalmology has seen the increasing use of biosimilars, especially in the treatment of retinal diseases like AMD, diabetic retinopathy, and retinal occlusion.
  • Anti-VEGF drugs, such as ranibizumab, aflibercept, and bevacizumab, are frequently used to inhibit abnormal blood vessel growth in these conditions.
  • Biosimilars of these anti-VEGF drugs offer a cost-effective way to manage these conditions, potentially reducing the financial burden on patients and healthcare systems. 

Benefits of Biosimilars:

  • Reduced costs:
    Biosimilars are generally less expensive than their reference biologics, making treatment more affordable and accessible.
  • Increased treatment :
    Lower costs can lead to better patient adherence to treatment regimens, improving overall outcomes.
  • Comparable efficacy and safety:
    Studies have shown that biosimilars are clinically equivalent to their reference products in terms of efficacy and safety. 

Examples of Biosimilars in Ophthalmology:

  • Byooviz (ranibizumab-nuna):
    The first FDA-approved ophthalmic biosimilar, indicated for neovascular AMD, macular edema following RVO, and myopic choroidal neovascularization. 

  • Other biosimilars:
    Several other biosimilars of ranibizumab, aflibercept, and bevacizumab are in development or have been approved for use in ophthalmology. 

Considerations:

  • While biosimilars offer significant benefits, it’s crucial that they undergo rigorous evaluation to demonstrate biosimilarity to the reference product.
  • Clinicians should be aware of the available biosimilars and their approved indications.
  • Patient education and communication are essential to ensure a smooth transition to biosimilar treatment. 
In conclusion, biosimilars are poised to play an increasingly important role in ophthalmology by providing more affordable and accessible treatment options for a range of retinal diseases.
Definition

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 15, 2025.

  1. Eye Diseases [rxharun.com]
  2. lucentis-epar-product-information-Eye Diseases [rxharun.com]
  3. jesc110 – Eye Diseases [rxharun.com]
  4. 9789240082458-eng [Eye Diseases (rxharun.com)]
  5. d1e1894daab433a1-9ed1066742d1-p67-Watson-et-al-v3 [Eye Diseases (rxharun.com)]
  6. PIIS0161642024000125 [Eye Diseases (rxharun.com)]
  7. OCT_in_Retinal_Diseases_Cozzi_EN [Eye Diseases (rxharun.com)]
  8. Eye76. Corneal Disorders [Eye Diseases (rxharun.com)]
  9. N.R. Galloway [Eye Diseases (rxharun.com)]
  10. OM – Definition & Classification [Eye Diseases (rxharun.com)]
  11. wcms_892937 [Eye Diseases (rxharun.com)]
  12. Diabetes1 [Eye Diseases (rxharun.com)]
  13. specific_eye_conditions [Eye Diseases (rxharun.com)]
  14. CEHJ95_Ocular-Surface-Disorders-1 [Eye Diseases (rxharun.com)]
  15. 17677-68019-2-PB [Eye Diseases (rxharun.com)]
  16. conditions [Eye Diseases (rxharun.com)]
  17. primary-care-approach-to-eye-conditions [Eye Diseases (rxharun.com)]
  18. Symptoms-Related-to-Eye-Diseases-and-Conditions-2 [Eye Diseases (rxharun.com)]
  19. Eye-Disease-Enc-eye-clopedia. [Eye Diseases (rxharun.com)]
  20. MCH-Conf-Mar-2019-6-Sandra-Staffieri-Clinical-Update-Paediatric-Eye-Disease [Eye Diseases (rxharun.com)]
  21. Adult-Hospital-Chapter-18-Eye-Disorders-with-supporting-NEMLC-report-and-reviews-2020-4-Version-1.0-30-September-2024 [Eye Diseases (rxharun.com)]
  22. hod0615i [Eye Diseases (rxharun.com)]
  23. The Cornea and Corneal Disease [Eye Diseases (rxharun.com)]
  24. August 2018 Feature [Eye Diseases (rxharun.com)]
  25. bpj54-pages8-21 [Eye Diseases (rxharun.com)]
  26. KaplanArianeDecember5CommonEye [Eye Diseases (rxharun.com)]
  27. ophthalmology-iv-handout-2016-17 [Eye Diseases (rxharun.com)]
  28. Common-Eye-Diseases-Ceu [Eye Diseases (rxharun.com)]
  29. externalEYE-DISEASE [Eye Diseases (rxharun.com)]
  30. EJHM_Volume 77_Issue 1_Pages 4754-4759 [Eye Diseases (rxharun.com)]
  31. Systemic [Eye Diseases (rxharun.com)]
  32. 9789241516570-eng [Eye Diseases (rxharun.com)]
  33. gp-handbook-common-eye-condition-management [Eye Diseases (rxharun.com)]
  34. Eye Care for FLW- Common Eye related conditions and Service Delivery Framework [Eye Diseases (rxharun.com)]
  35. hod0618i [Eye Diseases (rxharun.com)]
  36. Eye-Disorders-Guideline [Eye Diseases (rxharun.com)]
  37. kevt103 [Eye Diseases (rxharun.com)]
  38. Common Eye Diseases and their Management [Eye Diseases (rxharun.com)]
  39. eyediseases-book-aecp_Eng [Eye Diseases (rxharun.com)]

  1. https://www.aao.org/eye-health/
  2. https://www.nei.nih.gov/
  3. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases
  4. https://www.cdc.gov/vision-health/about-eye-disorders/index.html
  5. https://www.oxfordfamilyvisioncare.com/blog/different-types-of-eye-diseases/
  6. https://www.aoa.org/healthy-eyes/eye-and-vision-conditions
  7. https://www.fda.gov/media/124641/download
  8. https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
  9. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases
  10. https://www.ncbi.nlm.nih.gov/books/NBK22174/
  11. https://pubmed.ncbi.nlm.nih.gov/34201117/
  12. https://www.amazon.com/Eye-Book-Complete-Disorders-Hopkins/dp/1421440008
  13. https://www.amazon.com/Eye-Diseases-Disorders-Complete-Guide/dp/1922227323
  14. https://link.springer.com/book/10.1007/978-1-4471-3521-0
  15. https://www.ncbi.nlm.nih.gov/books/NBK582134/
  16. https://www.ncbi.nlm.nih.gov/books/NBK22174/
  17. https://www.ncbi.nlm.nih.gov/mesh?
  18. https://academic.oup.com/ije/article/29/5/951/821890
  19. https://en.wikipedia.org/wiki/Category:Eye_diseases
  20. https://en.wikipedia.org/wiki/Eye_disease
  21. https://medlineplus.gov/eyediseases.html
  22. https://eye.hms.harvard.edu/ormi
  23. https://www.cera.org.au/conditions/
  24. https://jamanetwork.com/journals/jama/fullarticle/2760387
  25. https://www.sciencedirect.com/topics/nursing-and-health-professions/eye-disease
  26. https://biotechhealthcare.com/common-eye-disorders-and-diseases/
  27. https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85&contentid=p00499
  28. https://pubmed.ncbi.nlm.nih.gov/35715505/
  29. https://www.sciencedirect.com/science/article/pii/S1934590918302315
  30. https://europe.ophthalmologytimes.com/view/bringing-biologics-to-eye-health-regenerative-medicine-for-inflammatory-disorders
  31. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
  32. https://www.nibib.nih.gov/
  33. https://www.nei.nih.gov/
  34. https://oxfordtreatment.com/
  35. https://www.nidcd.nih.gov/health/
  36. https://consumer.ftc.gov/articles/
  37. https://www.nccih.nih.gov/health
  38. https://catalog.ninds.nih.gov/
  39. https://www.aarda.org/diseaselist/
  40. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  41. https://www.nibib.nih.gov/
  42. https://www.nia.nih.gov/health/topics
  43. https://www.nichd.nih.gov/
  44. https://www.nimh.nih.gov/health/topics
  45. https://www.nichd.nih.gov/
  46. https://www.niehs.nih.gov/
  47. https://www.nimhd.nih.gov/
  48. https://www.nhlbi.nih.gov/health-topics
  49. https://obssr.od.nih.gov/.
  50. https://www.nichd.nih.gov/health/topics
  51. https://rarediseases.info.nih.gov/diseases
  52. https://beta.rarediseases.info.nih.gov/diseases
  53. https://orwh.od.nih.gov/

 

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Biosimilars in Ophthalmology

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

Internal learning pathway

Explore related RX articles

Related guides from RX Harun are grouped to help readers move from overview to symptoms, tests, treatment, and safe next steps.

Rx Eye & Vision Care (A - Z)
  1. Congenital Iris Ectropion DefinitionCongenital? iris? ectropion is more commonly called congenital ectropion uveae. It is a rare developmental eye…
  2. Congenital Cystic Eyeball DefinitionCongenital? cystic eyeball, also called congenital cystic eye, is a very rare birth defect? in which…
  3. Congenital Anophthalmos with Cyst DefinitionCongenital? anophthalmos with cyst is a very rare birth defect? of eye development. In this condition,…
  4. Congenital Cystic Eye DefinitionCongenital? cystic eye is a very rare birth condition. In this condition, a cyst-like sac grows…
  5. Cerulean Cataract DefinitionCerulean cataract is a rare kind of childhood or developmental cataract. A cataract means the natural…
  6. Congenital Blue Dot Cataract DefinitionCongenital? blue dot cataract, also called cerulean cataract, is a type of childhood lens opacity in…